Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the E
5 hours ago
- #GvHD prevention
- #myelofibrosis
- #allogeneic transplantation
- Study compares post-transplant cyclophosphamide (PTCy) versus anti-thymocyte globulin (ATG) in myelofibrosis patients with unrelated donors.
- Findings show decreased chronic graft-versus-host disease (GvHD) with PTCy compared to ATG.
- Research conducted by the Chronic Malignancies Working Party of the EBMT.
- Focuses on allogeneic hematopoietic stem cell transplantation outcomes.
- Highlights the importance of GvHD prevention strategies in unrelated donor transplants.